Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 02-2020 | 11-2019 | 08-2019 | 05-2019 | 02-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 740 | 1,333 | 1,285 | 1,996 | 3,093 |
| Marketable Securities | 24 | 23 | 64 | 75 | 71 |
| Receivables | 227 | 326 | 273 | 226 | 219 |
| Inventories | 124 | 134 | 127 | 188 | 108 |
| TOTAL | $1,180 | $1,912 | $1,819 | $2,608 | $3,641 |
| Non-Current Assets | |||||
| PPE Net | 538 | 565 | 591 | 607 | 433 |
| Intangibles | 268 | 269 | 265 | 243 | 200 |
| TOTAL | $806 | $835 | $856 | $850 | $633 |
| Total Assets | $1,986 | $2,746 | $2,675 | $3,457 | $4,274 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 62 | 93 | 136 | 111 | 495 |
| TOTAL | $63 | $130 | $185 | $132 | $500 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $63 | $130 | $185 | $132 | $500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,688 | 2,688 | 2,624 | 2,619 | 2,610 |
| Common Shares | 81 | 81 | 79 | 78 | 78 |
| Retained earnings | -25,726 | -24,776 | -23,868 | -22,790 | -21,618 |
| Other shareholders' equity | 43 | 90 | 108 | 146 | 995 |
| TOTAL | $1,923 | $2,616 | $2,491 | $3,325 | $3,774 |
| Total Liabilities And Equity | $1,986 | $2,746 | $2,675 | $3,457 | $4,274 |